Cramer’s lightning round: Vir and GlaxoSmithKline 'may have something' that could fight omicron

Norge Nyheter Nyheter

Cramer’s lightning round: Vir and GlaxoSmithKline 'may have something' that could fight omicron
Norge Siste Nytt,Norge Overskrifter
  • 📰 CNBC
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

“Mad Money” host Jim Cramer rings the lightning round bell on Vir Biotechnology, Enbridge, On Semiconductor and Robinhood.

Enbridge

: "That stock has just been in a house of pain. However, it does yield 7%. That's [CEO] Al Monaco. They've got a great long term business. I don't understand why it's going down, other than being brought down by the fact that oil suddenly went from $80 to $70 to $64. Buy Enbridge.": "We've had [CEO] Hassane El-Khoury on multiple times. I think he's a genius. He put together Cypress with this. He's got the best automobile chips.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

CNBC /  🏆 12. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Vir Biotechnology, Digital World Acquisition, Apple: What to Watch in the Stock Market TodayVir Biotechnology, Digital World Acquisition, Apple: What to Watch in the Stock Market TodayApple shares are slipping ahead of the open; Vir Biotechnology said its Covid-19 treatment had been successful in a study
Les mer »

COVID-19 Antibody Drug Likely Works Against Omicron, Companies SayCOVID-19 Antibody Drug Likely Works Against Omicron, Companies SayEarly lab studies show that a COVID-19 antibody treatment developed by GlaxoSmithKline and Vir Biotechnology could be effective against the Omicron variant.
Les mer »

What Jim Cramer is watching in the market Thursday, including Apple and BoeingWhat Jim Cramer is watching in the market Thursday, including Apple and BoeingInvesting Club: What Jim Cramer is watching in the market Thursday, including Apple and Boeing
Les mer »

GSK says tests indicate antibody drug works against OmicronGSK says tests indicate antibody drug works against OmicronLaboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday.
Les mer »

Oil rises on views OPEC+ may pause supply addition amid Omicron fearsOil rises on views OPEC+ may pause supply addition amid Omicron fearsOil prices rose on Thursday, reversing the previous day's losses, on expectations OPEC+ may pause supply additions amid growing concern the spread of the Omicron coronavirus variant could weigh on the global economy and fuel demand.
Les mer »



Render Time: 2025-04-06 15:55:46